Skip to main content
Premium Trial:

Request an Annual Quote

LifeCodexx, LifeCell Partner to Offer PrenaTest in India

NEW YORK (GenomeWeb) – LifeCodexx announced today that it has signed an agreement to sell its PrenaTest noninvasive prenatal screening test in India through preventative healthcare provider LifeCell.

According to LifeCodexx, LifeCell will offer the test under its BabyShield brand. Additional terms of the deal were not disclosed.

"We are very pleased to have partnered with LifeCell since they have a longstanding expertise in the field of preventive healthcare services for mother and child in the Indian market," LifeCodexx CEO Michael Lutz said in a statement.

Earlier this year, LifeCodexx partnered with Sengenics to sell PrenaTest in Southeast Asia. And last year, LifeCodexx forged alliances with other companies covering the UK and Ireland, Germany, and Switzerland.

The Scan

Study Links Genetic Risk for ADHD With Alzheimer's Disease

A higher polygenic risk score for attention-deficit/hyperactivity disorder is also linked to cognitive decline and Alzheimer's disease, a new study in Molecular Psychiatry finds.

Study Offers Insights Into Role of Structural Variants in Cancer

A new study in Nature using cell lines shows that structural variants can enable oncogene activation.

Computer Model Uses Genetics, Health Data to Predict Mental Disorders

A new model in JAMA Psychiatry finds combining genetic and health record data can predict a mental disorder diagnosis before one is made clinically.

Study Tracks Off-Target Gene Edits Linked to Epigenetic Features

Using machine learning, researchers characterize in BMC Genomics the potential off-target effects of 19 computed or experimentally determined epigenetic features during CRISPR-Cas9 editing.